Large-scale testing (Phase 3)Ended earlyNCT03315143
What this trial is testing
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Who this might be right for
Heart FailureType 2 Diabetes MellitusChronic Kidney Diseases
Lexicon Pharmaceuticals 10,584